109 related articles for article (PubMed ID: 12383965)
1. Impaired axonal transport of cortical neurons in Alzheimer's disease is associated with neuropathological changes.
Dai J; Buijs RM; Kamphorst W; Swaab DF
Brain Res; 2002 Sep; 948(1-2):138-44. PubMed ID: 12383965
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid hormone (cortisol) affects axonal transport in human cortex neurons but shows resistance in Alzheimer's disease.
Dai J; Buijs R; Swaab D
Br J Pharmacol; 2004 Nov; 143(5):606-10. PubMed ID: 15466441
[TBL] [Abstract][Full Text] [Related]
3. The origin and development of plaques and phosphorylated tau are associated with axonopathy in Alzheimer's disease.
Xiao AW; He J; Wang Q; Luo Y; Sun Y; Zhou YP; Guan Y; Lucassen PJ; Dai JP
Neurosci Bull; 2011 Oct; 27(5):287-99. PubMed ID: 21934724
[TBL] [Abstract][Full Text] [Related]
4. A novel fluorescent method for direct visualization of neurofibrillary pathology in Alzheimer's disease.
Sun A; Nguyen XV; Bing G
J Neurosci Methods; 2001 Oct; 111(1):17-27. PubMed ID: 11574116
[TBL] [Abstract][Full Text] [Related]
5. The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.
Gómez-Isla T; Growdon WB; McNamara MJ; Nochlin D; Bird TD; Arango JC; Lopera F; Kosik KS; Lantos PL; Cairns NJ; Hyman BT
Brain; 1999 Sep; 122 ( Pt 9)():1709-19. PubMed ID: 10468510
[TBL] [Abstract][Full Text] [Related]
6. Neurofibrillary tangles in elderly patients with late onset schizophrenia.
Bozikas VP; Kövari E; Bouras C; Karavatos A
Neurosci Lett; 2002 May; 324(2):109-12. PubMed ID: 11988339
[TBL] [Abstract][Full Text] [Related]
7. Localized cortical chronic traumatic encephalopathy pathology after single, severe axonal injury in human brain.
Shively SB; Edgerton SL; Iacono D; Purohit DP; Qu BX; Haroutunian V; Davis KL; Diaz-Arrastia R; Perl DP
Acta Neuropathol; 2017 Mar; 133(3):353-366. PubMed ID: 27885490
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease as a disconnection syndrome?
Delbeuck X; Van der Linden M; Collette F
Neuropsychol Rev; 2003 Jun; 13(2):79-92. PubMed ID: 12887040
[TBL] [Abstract][Full Text] [Related]
9. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients.
Montine TJ; Markesbery WR; Zackert W; Sanchez SC; Roberts LJ; Morrow JD
Am J Pathol; 1999 Sep; 155(3):863-8. PubMed ID: 10487843
[TBL] [Abstract][Full Text] [Related]
10. Microanatomical correlates of cognitive ability and decline: normal ageing, MCI, and Alzheimer's disease.
Chance SA; Clover L; Cousijn H; Currah L; Pettingill R; Esiri MM
Cereb Cortex; 2011 Aug; 21(8):1870-8. PubMed ID: 21239393
[TBL] [Abstract][Full Text] [Related]
11. Myelin basic protein associates with AβPP, Aβ1-42, and amyloid plaques in cortex of Alzheimer's disease brain.
Zhan X; Jickling GC; Ander BP; Stamova B; Liu D; Kao PF; Zelin MA; Jin LW; DeCarli C; Sharp FR
J Alzheimers Dis; 2015; 44(4):1213-29. PubMed ID: 25697841
[TBL] [Abstract][Full Text] [Related]
12. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.
Newell KL; Hyman BT; Growdon JH; Hedley-Whyte ET
J Neuropathol Exp Neurol; 1999 Nov; 58(11):1147-55. PubMed ID: 10560657
[TBL] [Abstract][Full Text] [Related]
13. Early and persistent alterations in prefrontal cortex MAO A and B in Alzheimer's disease.
Kennedy BP; Ziegler MG; Alford M; Hansen LA; Thal LJ; Masliah E
J Neural Transm (Vienna); 2003 Jul; 110(7):789-801. PubMed ID: 12811639
[TBL] [Abstract][Full Text] [Related]
14. Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.
Terwel D; Dewachter I; Van Leuven F
Neuromolecular Med; 2002; 2(2):151-65. PubMed ID: 12428809
[TBL] [Abstract][Full Text] [Related]
15. Relationship between plaques, tangles, and loss of cortical cholinergic fibers in Alzheimer disease.
Geula C; Mesulam MM; Saroff DM; Wu CK
J Neuropathol Exp Neurol; 1998 Jan; 57(1):63-75. PubMed ID: 9600198
[TBL] [Abstract][Full Text] [Related]
16. Neuropathological and clinical phenotype of an Italian Alzheimer family with M239V mutation of presenilin 2 gene.
Marcon G; Giaccone G; Cupidi C; Balestrieri M; Beltrami CA; Finato N; Bergonzi P; Sorbi S; Bugiani O; Tagliavini F
J Neuropathol Exp Neurol; 2004 Mar; 63(3):199-209. PubMed ID: 15055444
[TBL] [Abstract][Full Text] [Related]
17. In situ labeling of dying cortical neurons in normal aging and in Alzheimer's disease: correlations with senile plaques and disease progression.
Troncoso JC; Sukhov RR; Kawas CH; Koliatsos VE
J Neuropathol Exp Neurol; 1996 Nov; 55(11):1134-42. PubMed ID: 8939196
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of hnRNP B1 in the postmortem temporal cortices of patients with Alzheimer's disease.
Ishikawa M; Mizukami K; Iwakiri M; Kamma H; Ikonomovic MD; Dekosky ST; Asada T
Neurosci Res; 2004 Dec; 50(4):481-4. PubMed ID: 15567486
[TBL] [Abstract][Full Text] [Related]
19. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
Guo H; Albrecht S; Bourdeau M; Petzke T; Bergeron C; LeBlanc AC
Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
